Rifaximin-α in alcohol-associated liver disease

被引：1
作者：
Xie, Chencheng [1 ,2 ]
Singal, Ashwani K. [1 ,2 ,3 ]
机构：
[1] Univ South Dakota, Sanford Sch Med, Dept Med, Sioux Falls, SD 57105 USA
[2] Avera Transplant Inst, Div Transplant Hepatol, Sioux Falls, SD 57105 USA
[3] VA Med Ctr, Sioux Falls, SD 57105 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2023年 / 8卷 / 06期
关键词：
D O I：
10.1016/S2468-1253(23)00033-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：495 / 497
页数：3
相关论文
共 9 条
  • [1] Covid-19 and alcohol associated liver disease
    Deutsch-Link, Sasha
    Curtis, Brenda
    Singal, Ashwani K.
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 (11) : 1459 - 1468
  • [2] Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis
    Enomoto, Masahide
    Kaji, Kosuke
    Nishimura, Norihisa
    Fujimoto, Yuki
    Murata, Koji
    Takeda, Soichi
    Tsuji, Yuki
    Fujinaga, Yukihisa
    Takaya, Hiroaki
    Kawaratani, Hideto
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1392 - 1402
  • [3] Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
    Huang, Daniel Q.
    Mathurin, Philippe
    Cortez-Pinto, Helena
    Loomba, Rohit
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (01) : 37 - 49
  • [4] Rifaximin-a for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
    Israelsen, Mads
    Madsen, Bjorn Staehr
    Torp, Nikolaj
    Johansen, Stine
    Hansen, Camilla Dalby
    Detlefsen, Sonke
    Andersen, Peter
    Hansen, Johanne Kragh
    Lindvig, Katrine Prier
    Rasmussen, Ditlev Nytoft
    Thorhauge, Katrine Holtz
    Kjaergaard, Maria
    Karsdal, Morten
    Hansen, Torben
    Arumugam, Manimozhiyan
    Trebicka, Jonel
    Thiele, Maja
    Krag, Aleksander
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (06): : 523 - 532
  • [5] Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
    Jian, Jie
    Nie, Mei-Tong
    Xiang, Baoyu
    Qian, Hui
    Yin, Chuan
    Zhang, Xin
    Zhang, Menghui
    Zhu, Xuan
    Xie, Wei-Fen
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)
    Jimenez, Cesar
    Ventura-Cots, Meritxell
    Sala, Margarita
    Calafat, Margalida
    Garcia-Retortillo, Montserrat
    Cirera, Isabel
    Canete, Nuria
    Soriano, German
    Poca, Maria
    Simon-Talero, Macarena
    Altamirano, Jose
    Lucey, Michael
    Garcia-Tsao, Guadalupe
    Brown, Robert S., Jr.
    Schwabe, Robert F.
    Verna, Elizabeth C.
    Schnabl, Bernd
    Bosques-Padilla, Francisco
    Mathurin, Philippe
    Caballeria, Juan
    Louvet, Alexandre
    Shawcross, Debbie L.
    Abraldes, Juan G.
    Genesca, Joan
    Bataller, Ramon
    Vargas, Victor
    [J]. LIVER INTERNATIONAL, 2022, 42 (05) : 1109 - 1120
  • [7] The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
    Kimer, Nina
    Meldgaard, Mads
    Hamberg, Ole
    Kronborg, Thit Mynster
    Lund, Allan M.
    Moller, Holger Jon
    Bendtsen, Flemming
    Ytting, Henriette
    [J]. PLOS ONE, 2022, 17 (03):
  • [8] Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
    Patel, Vishal C.
    Lee, Sunjae
    McPhail, Mark J. W.
    Da Silva, Kevin
    Guilly, Susie
    Zamalloa, Ane
    Witherden, Elizabeth
    Stoy, Sidsel
    Vijay, Godhev Kumar Manakkat
    Pons, Nicolas
    Galleron, Nathalie
    Huang, Xaiohong
    Gencer, Selin
    Coen, Muireann
    Tranah, Thomas Henry
    Wendon, Julia Alexis
    Bruce, Kenneth D.
    Le Chatelier, Emmanuelle
    Ehrlich, Stanislav Dusko
    Edwards, Lindsey Ann
    Shoaie, Saeed
    Shawcross, Debbie Lindsay
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (02) : 332 - 342
  • [9] Diagnosis and Treatment of Alcohol-Associated Liver Disease A Review
    Singal, Ashwani K.
    Mathurin, Philippe
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (02): : 165 - 176
1